» Articles » PMID: 34879069

Very High Prevalence of Infection with the Human T Cell Leukaemia Virus Type 1c in Remote Australian Aboriginal Communities: Results of a Large Cross-sectional Community Survey

Overview
Date 2021 Dec 8
PMID 34879069
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Infection with the human T cell leukaemia virus type 1 (HTLV-1) subtype C is endemic among Aboriginal people in central Australia. To provide insights into the risk factors for transmission, we conducted the first large-scale, community-based prevalence study in seven remote Aboriginal communities. Residents >2 years old were invited to participate in the study between August 2014 and June 2018. HTLV-1 infection was defined as a positive western blot (WB) test or a positive HTLV-1 PCR. 720 community residents participated in the study (children <15 years, 142; adults, 578). Prevalences for children and adults were 3.5% (5/142) and 36.8% (213/578), respectively, reaching 49.3% (106/215) for those older than 45 years. A wide range of proviral loads were measured for both asymptomatic and symptomatic participants with no difference within groups according to age or gender; however, median PVL was 1.34 log10 higher for symptomatic participants. The adult prevalence of HTLV-1 infection in central Australia is the highest reported worldwide. Sexual contact is likely to be the predominant mode of transmission.

Citing Articles

The Global Prevalence of HTLV-1 and HTLV-2 Infections among Immigrants and Refugees-A Systematic Review and Meta-Analysis.

Marinho T, Okita M, Guimaraes R, de Sene Amancio Zara A, Caetano K, Teles S Viruses. 2024; 16(10).

PMID: 39459861 PMC: 11512286. DOI: 10.3390/v16101526.


A promising advance in blocking HTLV-1 transmission: Addressing a global public health problem.

Vallinoto A Mol Ther. 2024; 32(7):2050-2051.

PMID: 38908379 PMC: 11286807. DOI: 10.1016/j.ymthe.2024.06.010.


Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques.

Nakamura-Hoshi M, Ishii H, Nomura T, Nishizawa M, Hau T, Kuse N Mol Ther. 2024; 32(7):2328-2339.

PMID: 38734900 PMC: 11286815. DOI: 10.1016/j.ymthe.2024.05.020.


HTLV-1 Proliferation after CD8 Cell Depletion by Monoclonal Anti-CD8 Antibody Administration in Latently HTLV-1-Infected Cynomolgus Macaques.

Nakamura-Hoshi M, Nomura T, Nishizawa M, Hau T, Yamamoto H, Okazaki M Microbiol Spectr. 2023; 11(4):e0151823.

PMID: 37367230 PMC: 10434050. DOI: 10.1128/spectrum.01518-23.


abscess mimicking sarcoma in a HTLV-1-infected Indigenous Australian man: Case report and literature review.

Susanto M, Dunning J, Chew R Clin Case Rep. 2023; 11(5):e7351.

PMID: 37215972 PMC: 10196424. DOI: 10.1002/ccr3.7351.


References
1.
Einsiedel L, Pham H, Au V, Hatami S, Wilson K, Spelman T . Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study. ERJ Open Res. 2020; 5(4). PMC: 6939737. DOI: 10.1183/23120541.00001-2019. View

2.
Kaplan J, Khabbaz R, Murphy E, Hermansen S, Roberts C, Lal R . Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 12(2):193-201. DOI: 10.1097/00042560-199606010-00014. View

3.
Gessain A, Barin F, Vernant J, Gout O, Maurs L, Calender A . Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985; 2(8452):407-10. DOI: 10.1016/s0140-6736(85)92734-5. View

4.
Verdonck K, Gonzalez E, Van Dooren S, Vandamme A, Vanham G, Gotuzzo E . Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007; 7(4):266-81. DOI: 10.1016/S1473-3099(07)70081-6. View

5.
Hino S . Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki. Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87(4):152-66. PMC: 3149377. DOI: 10.2183/pjab.87.152. View